News Conference News ACC 2026 Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF Caitlin E. Cox April 02, 2026
News Conference News ACC 2026 Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease Todd Neale April 01, 2026
News Conference News ACC 2026 SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3 Yael L. Maxwell March 29, 2026
News Conference News ACC 2026 Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI Michael O'Riordan March 28, 2026
News Daily News Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On Todd Neale March 26, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Conference News CRT 2026 DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients L.A. McKeown March 09, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Daily News Advanced HF in Finland: Costs, Survival Diverge for Elective vs Urgent LVAD Caitlin E. Cox March 06, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Conference News THT 2026 Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought Todd Neale March 04, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
Presentation THT 2026 Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support Presenter: Sudhir Kushwaha March 04, 2026
Presentation THT 2026 Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial Presenter: Sheldon E. Litwin March 04, 2026
Presentation THT 2026 Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era Presenter: Francis D. Pagani March 04, 2026